IKBKB and familial pancreatic carcinoma: Xie et al. (2017) designed a series of EF24 analogues, finding one that showed excellent inhibition of both inhibitor of nuclear factor kappa-β kinase subunit beta (IKKβ) activity and pancreatic cancer development [123].